<DOC>
	<DOCNO>NCT02285192</DOCNO>
	<brief_summary>The purpose study see radioactive substance call 18F-Fluorodeoxyglucose ( 18F- FDG ) , inject cervix PET/CT scan do surgery show u clearly lymph node pelvis ( area near uterus cervix ) contain cancer .</brief_summary>
	<brief_title>Positron Lymphography Via Intracervical 18F-FDG Injection Pre-surgical Lymphatic Mapping Stage IB1 Cervical Cancer High-grade Endometrial Cancer</brief_title>
	<detailed_description />
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Endometrial Neoplasms</mesh_term>
	<mesh_term>Fluorodeoxyglucose F18</mesh_term>
	<criteria>The study population include woman stage IB1 cervical cancer ( histologic subtype ) deem eligible surgery , woman clinical stage I highgrade endometrial cancer plan undergo surgical staging . High grade define follow : Uterine serous carcinoma Clear cell endometrial carcinoma Grade 3 endometrioid carcinoma Endometrial carcinosarcoma Clinical stage I grade 12 endometrial cancer also eligible deep myoinvasion ≥ 50 % show preop MRI and/or elevate preop CA125 &gt; 35 U/ml . Age ≥18 year Hemoglobin ≥10 g/dL Plasma albumin ≥3 g/dL GOG performance status ≤2 Plasma glucose ≤200 mg/dL Plasma creatinine ≤1.6 Wellcontrolled hypertension Medical clearance surgery consider appropriate surgical candidate Negative serum pregnancy test , childbearing potential If , base surgeon 's assessment , patient recommend undergo surgical stag histologically confirm endometrial cancer IB1 cervical cancer deem eligible surgical treatment disease Participation research protocols exclude patient participation study Hemoglobin &lt; 10 g/dL Plasma albumin &lt; 3 g/dL GOG performance status &gt; 2 Plasma glucose &gt; 200 mg/dL Renal insufficiency plasma creatinine &gt; 1.6 Uncontrolled hypertension Patient meet medical clearance surgery consider appropriate surgical candidate Pregnancy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>18F-FDG Injection</keyword>
	<keyword>Positron Lymphography</keyword>
	<keyword>Lymphatic Mapping</keyword>
	<keyword>sentinel lymph node</keyword>
	<keyword>PET/CT</keyword>
	<keyword>14-222</keyword>
</DOC>